The Gluten in Medication Disclosure Act was introduced by Senator Richard Blumenthal from Connecticut in 2019 and uses the same language as the bill introduced to the House of Representatives in April 2019. For gluten sensitive individuals and especially those with celiac disease, it is imperative that this bill is passed by Congress.
At this point in time, there is no legislation that requires a medication manufacturer to list potential gluten-containing ingredients on their labels. The Gluten in Medication Disclosure Act is “A bill to amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.”
Your Direct Action Is Needed!
Citizens must show their support for this bill and ask their representatives and senators to co-sponsor. Here’s how you do it:
- Contact your senators and ask them to co-sponsor the bill. You can find a sample letter at National Celiac Association’s web site.
- You can also contact your Representatives asking them to co-sign as a sponsor of the House bill. A sample letter to the House of Representatives can also be found at National Celiac Assocation’s web site.
You can count on us to continue to keep you updated on the progress of this extremely important piece of legislation.